Yahoo Web Suche

  1. Anzeige

    zum Thema: celgene stock
  2. ON's new earnings have just been released, discover why they're capturing attention. ON Semiconductor's new earnings report is here, our experts inform you in our free report

Suchergebnisse

  1. Vor 11 Stunden · BMY increased its quarterly dividend payout early this year from $0.57 a share to $0.60 (a 5.26% increase). It has paid and raised the dividend payout for the last 18 years. The past 5-year ...

  2. Vor 5 Tagen · Celgene has signed a deal with Vividion Therapeutics to develop drugs for oncology, inflammatory, and neurodegenerative diseases. The new collaboration comes after a number of major setbacks for...

  3. Vor 3 Tagen · Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData.

  4. Vor 5 Tagen · Bristol-Myers Squibb has announced its new-look leadership after the Celgene takeover goes through, and it reveals a mixed bag of new hires, sideways moves, and departures.

  5. Vor 5 Tagen · PURPOSE Nivolumab plus relatlimab and nivolumab plus ipilimumab have been approved for advanced melanoma on the basis of the phase II/III RELATIVITY-047 and phase III CheckMate 067 trials, respectively. As no head-to-head trial comparing these regimens exists, an indirect treatment comparison was conducted using patient-level data from each trial. METHODS Inverse probability of treatment ...

  6. Vor 3 Tagen · Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  7. Vor 4 Tagen · Allergan AKTIE (ISIN: IE00BY9D5467): Realtime-Kurs der Allergan Aktie in EUR Analysen & Performance aktuelle Nachrichten ⇒ die nächsten Kursziele.

  1. Anzeige

    zum Thema: celgene stock
  2. ON's new earnings have just been released, discover why they're capturing attention. ON Semiconductor's new earnings report is here, our experts inform you in our free report